Vivani Medical, Inc. (VANI)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-27

Key Insights

Vivani Medical, Inc. raised approximately $2.0 million through a private placement of 1,351,351 shares of common stock at $1.48 per share, which could strengthen the company's financial position.
Concurrently, the company raised an additional $2.5 million through a registered direct offering of 1,689,200 shares of common stock, which could provide additional capital for operations or growth initiatives.
The private placement was made with an entity affiliated with the company's Chairman, Gregg Williams, which could signal alignment between management and investors.

Insider Trading Filed: 2026-01-20

Key Insights

The reporting person, Gregg Williams, has made significant purchases of Vivani Medical, Inc. (VANI) common stock through private transactions, acquiring over 1.7 million shares at an average price of $1.19 per share.
Gregg Williams holds a substantial ownership stake in Vivani Medical, directly and indirectly controlling over 31.3 million shares, or approximately 59% of the company's outstanding common stock.
The large insider buying activity and concentrated ownership by Gregg Williams suggest that he has a strong conviction in the company's future prospects.

Insider Trading Filed: 2025-12-31

Key Insights

The reporting person, Aaron Mendelsohn, acquired 20,000 shares of Vivani Medical, Inc. (VANI) common stock on December 29, 2025 at $1.23 per share, increasing their direct beneficial ownership to 188,170 shares.
Mendelsohn also owns 898,317 shares indirectly through various trusts and a limited liability company, for a total beneficial ownership of 1,086,487 shares or approximately 10% of the company.
The reporting person previously gifted 20,000 shares to a non-affiliated entity on July 8, 2024, which was not previously disclosed in a timely Form 4 filing.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.